LONDON, ONTARIO--(CCNMatthews - Oct. 21, 2005) - Stellar Pharmaceuticals Inc. (“Stellar”) (TSX VENTURE:SLX)(OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that it has been ranked the 200th fastest growing technology company in North America on the 2005 Deloitte Technology Fast 500 list. Stellar was one of 53 Canadian companies included in the list, which noted the Company’s 805% revenue growth over the past five years.
